Delaware will treat all Medicaid patients with hepatitis C | Philly.com
The state of Delaware said Tuesday that it would phase in a new policy to treat all hepatitis C patients in its Medicaid program. States have been under pressure from the Obama Administration and lawsuits to abandon money-saving policies that limited treatment with effective but costly new medications to the sickest patients.
Miami-Dade commissioners vote to let Jackson Health keep profits | Miami Herald
Miami-Dade County commissioners on Tuesday took swift action to prevent themselves from doing two things they haven't attempted in more than a decade: appropriating the profits of Jackson Health System and imposing “unfunded mandates” on the taxpayer owned healthcare provider.
Wyoming Medical Center lays off 58 workers, says Medicaid expansion would have prevented some | (Casper, Wyo.) Star-Tribune
Wyoming Medical Center laid off 58 workers Tuesday, compounding the woes of a state already suffering from increasing unemployment and a stagnant energy sector. The job cuts are expected to save the Casper hospital $7.2 million, or 3.4% of the hospital's forecast total expenses this year of $213.3 million.
L.A.'s Gardens Regional Hospital files for bankruptcy | Wall Street Journal
The Gardens Regional Hospital and Medical Center filed for bankruptcy after losing money providing healthcare to depressed southern Los Angeles neighborhoods, where fewer patients can afford the cost of healthcare.
Ebola nurse Nina Pham's attorneys say hospital won't reveal details of how disease spread | Dallas Morning News
After the Ebola crisis in Dallas two years ago, Texas Health Resources pledged to share what it learned about how the disease spread from a single patient who died to two nurses who cared for him at its Dallas hospital. But attorneys for one of the nurses, Nina Pham, who is suing THR, say the company isn't living up to the promise it made to the city, medical community and Congress.
Doctors, telemedicine companies meet to plot new course in Texas | The Texas Tribune
Though many expected a messy fight over Texas' telemedicine rules next year, medical and industry groups are coming together to try to hammer out a compromise over how healthcare can be provided remotely.
Feds may be warming up to Sarepta's Duchenne drug | Stat
Shares of Cambridge, Mass.-based Sarepta shot up more than 25% Tuesday after news that the FDA would review more data about the company's treatment for Duchenne muscular dystrophy. The rare disease has proven difficult to treat with drugs, but investors viewed the FDA's interest as a good sign.
